Breast Imaging
    
  
      Breast MRI
  
            Find your care
      
    
          We offer the full breadth of services to screen for and diagnose breast cancer. To learn more about breast imaging services, call 310-301-6800.
Recommendations for Breast MRI Screening as an Adjunct to Mammography
Recommend Annual MRI Screening (Based on Evidence*)
- BRCA mutation
 - First-degree relative of BRCA carrier, but untested
 - Lifetime risk ~20-25% or greater, as defined by BRCAPRO or other models that are largely dependent on family history
 
Recommend Annual MRI Screening (Based on Expert Consensus Opinion**)
- Radiation to chest between age 10 and 30 years
 - Li-Fraumeni syndrome and first-degree relatives
 - Cowden and Bannayan-Riley-Ruvalcaba syndromes and first-degree relatives
 
Insufficient Evidence to Recommend for or Against MRI Screening***
- Lifetime risk 15-20%, as defined by BRCAPRO or other models that are largely dependent on family history
 - Lobular carcinoma in situ (LCIS) or atypical lobular hyperplasia (ALH)
 - Atypical ductal hyperplasia (ADH)
 - Heterogeneously or extremely dense breast on mammography
 - Women with a personal history of breast cancer, including ductal carcinoma in situ (DCIS)
 
Recommend Against MRI Screening (Based on Expert Consensus Opinion)
- Women at <15% lifetime risk
 
- * Evidence from nonrandomized screening trials and observational studies.
 - ** Based on evidence of lifetime risk for breast cancer.
 - *** Payment should not be a barrier. Screening decisions should be made on a case-by-case basis, as there may be particular factors to support MRI. More data on these groups is expected to be published soon.